News
New tool enables researchers to assemble transcript isoforms from single cells
The advent of single-cell RNA sequencing technologies has provided unprecedented opportunities for the analysis of transcriptomes at single-cell resolution, allowing researchers to explore cell-to-cell variability. Now, researchers have developed a tool for the analysis and identification of RNA isoforms from single-cell RNA sequencing data.
Cancer drug synergizes with radiation therapy in treatment-resistant prostate cancer
An in-depth analysis of cervical cancers in Ugandan women
Cervical cancer disproportionately affects women in sub-Saharan Africa where it is the most common cancer-related mortality and has disease rates higher than any other region in the world (1). Yet studies of the disease have predominantly focused on non-African populations.
An international team of researchers, in work led by Canada’s Michael Smith Genome Sciences Centre (GSC) at BC Cancer, have now published an analysis of the genomic characteristics of cervical cancers in Ugandan women.
A framework for the management of inherited genetic variation impacting cancer patients and their families
Cell recycling mechanism may inform breast cancer patient prognosis
A hallmark mutation may be the Achilles heel for adult granulosa cell tumours of the ovary
A novel tool for simultaneous classification of DNA from multiple species
Gene Machines: an acoustic exploration of genome science
In commemoration of our 20th anniversary, Vancouver-based electronic music producer Segue was commissioned to create an original composition based on audio recordings from the GSC's laboratory equipment, robots and computers—to make “music” from the noise they produce.
DNA sequencing reveals mechanisms of treatment resistance in patients with diffuse large B cell lymphoma
When treatment with frontline therapeutics fails for patients with diffuse large B cell lymphoma (DLBCL), prognosis is very poor. By sequencing tumour DNA from patients with relapsed disease, researchers have now uncovered genetic mutations that contribute to treatment failure and resistance, paving the way to better treatment strategies.
Canada’s Michael Smith Genome Sciences Centre respectfully acknowledges that we operate on the traditional, ancestral and unceded territories of the xʷməθkwəy̓əm (Musqueam), Səl̓ílwətaʔ/Selilwitulh (Tsleil-Waututh), and Skwxwú7mesh (Squamish) nations who have cared and nurtured this land for all time. We give thanks, as uninvited guests, to be able to live and work on these lands.